CDXS Codexis, Inc. - Common Stock
$1,57
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 11, 2026
Zakres 52 tyg.
$1–$3
29% of range
Ocena Analityków
BUY
13 analysts
Cena Docelowa
$6
+315% upside
P/E (TTM)
-3.1
ROE
-82.8%
Marża Zysku Netto
-62.5%
O Codexis, Inc. - Common Stock Przegląd firmy z Wikipedii
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Czytaj więcej
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
History
Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.
Pharmaceutical
Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.
Nutrition
In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.
Biotherapeutics
In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.
In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.
Life science
In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.
Technology
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CDXS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.56
Kapitalizacja Rynkowa
$142M
P/E (TTM)
-3.1
EPS (TTM)
$-0.50
Przychody (TTM)
$70M
Stopa dywidendy
—
ROE
-82.8%
D/E Dług/Kapitał
0.8
Zakres 52 tyg.
$1 – $3
CDXS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$70M
2016-12-31
→
2025-12-31
EPS
$-0.50
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-24M
2016-12-31
→
2025-12-31
Marże
-62.5%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CDXS
Mediana porównawcza
P/E (TTM)
-3.1
17.5
P/S (TTM)
2.0
3.3
P/B
2.8
2.1
EV / EBITDA
-2.8
—
Price / FCF (Cena / FCF)
-5.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CDXS
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-59.3%
—
Net Profit Margin (Marża Zysku Netto)
-62.5%
-56.5%
ROA
-29.6%
-17.2%
ROE
-82.8%
-41.3%
ROIC
-46.1%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CDXS
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.8
369.6
Current Ratio (Wskaźnik bieżący)
3.8
4.9
Quick Ratio (Wskaźnik Szybkości)
3.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CDXS
Mediana porównawcza
Revenue YoY (Przychody R/R)
18.6%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-20.2%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
0.38%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CDXS
Mediana porównawcza
CDXS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
13 analityków
- Mocne kupno 4 30,8%
- Kup 6 46,2%
- Trzymaj 3 23,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-20
Mediana
$7.00
← Poniżej wszystkich celów
$1.56
Niski
$2.00
Wysoki
$11.00
Średni cel
$7.00
+347,3%
Średnia cel
$6.50
+315,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.13 | $-0.14 | 0.01% |
| 31 marca 2026 | $-0.10 | $-0.14 | 0.04% |
| 31 grudnia 2025 | $0.11 | $-0.04 | 0.15% |
| 30 września 2025 | $-0.22 | $-0.15 | -0.07% |
| 30 czerwca 2025 | $-0.16 | $-0.19 | 0.03% |
| 31 marca 2025 | $-0.25 | $-0.24 | -0.01% |
| 31 grudnia 2024 | $-0.13 | $-0.04 | -0.09% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
| OABI | — | — | — | — | — | — |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| QSI | — | — | — | — | — | — |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| NAUT | $247M | -4.1 | — | — | -34.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Cost of Revenue | $9M | $16M | $13M | $38M | $22M | $14M | $16M | $13M | $14M | $10M | $7M | $10M | |
| R&D Expense | $52M | $46M | $59M | $80M | $56M | $44M | $34M | $30M | $30M | $22M | $21M | $23M | |
| SG&A Expense | $47M | $55M | $53M | $52M | $49M | $35M | $32M | $29M | $29M | $25M | $22M | $22M | |
| Operating Expenses | $112M | $118M | $138M | $173M | $127M | $93M | $81M | $72M | $73M | $57M | $50M | $54M | |
| Operating Income | $-42M | $-59M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Interest Income | $3M | $4M | $4M | $1M | $459.0K | $405.0K | $1M | $671.0K | $147.0K | $60.0K | $19.0K | $18.0K | |
| Other Non-op | $-5M | $-10M | $-12M | $124.0K | $1M | $-156.0K | $-656.0K | $-291.0K | $-92.0K | $-94.0K | · | · | |
| Pretax Income | $-44M | $-65M | $-76M | $-33M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Income Tax | $47.0K | $34.0K | $69.0K | $276.0K | $189.0K | $339.0K | $17.0K | $-37.0K | $81.0K | $-40.0K | $-338.0K | $-256.0K | |
| Net Income | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| EPS (Basic) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| EPS (Diluted) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| Shares (Basic) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| Shares (Diluted) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| EBITDA | $-36M | $-54M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M |
Bilans 29
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $19M | $65M | $114M | $117M | $149M | $90M | $53M | $31M | $19M | $23M | $26M | |
| Short-term Investments | $27M | $54M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | $10M | $32M | $25M | $14M | $9M | $12M | $11M | $6M | $7M | $4M | |
| Inventory | $2M | $2M | $3M | $2M | $1M | $964.0K | $371.0K | $589.0K | $1M | $825.0K | $992.0K | $1M | |
| Prepaid Expense | $6M | $4M | $5M | $5M | $6M | $3M | $3M | $1M | $984.0K | $1M | $1M | $1M | |
| Other Current Assets | $500.0K | $500.0K | $600.0K | $700.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $97M | $99M | $93M | $163M | $162M | $184M | $114M | $68M | $45M | $27M | $33M | $33M | |
| PP&E (Net) | $13M | $14M | $15M | $23M | $21M | $10M | $6M | $5M | $3M | $2M | $3M | $4M | |
| PP&E (Gross) | $58M | $55M | $55M | $62M | $57M | $43M | $40M | $38M | $35M | $34M | $35M | $37M | |
| Accum. Depreciation | $45M | $41M | $39M | $40M | $36M | $33M | $33M | $33M | $32M | $32M | $32M | $31M | |
| Goodwill | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | · | · | · | · | · | · | · | · | · | $0 | $3M | $6M | |
| Other Non-current Assets | $883.0K | $1M | $1M | $350.0K | $276.0K | $294.0K | $178.0K | $1M | $302.0K | $259.0K | $310.0K | $294.0K | |
| Total Assets | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Accounts Payable | $2M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $5M | |
| Accrued Liabilities | $3M | $6M | $5M | $15M | $13M | $10M | $7M | $5M | $4M | $2M | $2M | $3M | |
| Current Liabilities | $25M | $24M | $36M | $49M | $33M | $25M | $15M | $18M | $25M | $12M | $15M | $14M | |
| Capital Leases | $30M | $28M | $12M | $38M | $44M | $22M | $25M | $61.0K | $302.0K | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $97M | $82M | $50M | $106M | $82M | $52M | $44M | $23M | $29M | $17M | $22M | · | |
| Long-term Debt | $40M | $29M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $40M | $29M | · | · | · | · | · | · | $302.0K | · | · | · | |
| Common Stock | $9.0K | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $657M | $630M | $584M | $566M | $552M | $537M | $448M | $387M | $340M | $311M | $306M | $302M | |
| Retained Earnings | $-607M | $-563M | $-498M | $-421M | $-388M | $-366M | $-342M | $-330M | $-315M | $-292M | $-284M | $-276M | |
| AOCI | $8.0K | $52.0K | $0 | · | · | · | · | $0 | $-472.0K | $0 | $405.0K | $-142.0K | |
| Stockholders' Equity | $51M | $67M | $87M | $145M | $164M | $170M | $106M | $56M | $25M | $19M | $23M | $26M | |
| Liabilities + Equity | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Shares Outstanding | 90,478,000 | 81,850,000 | 69,905,000 | 65,811,000 | 65,109,000 | 64,283,000 | 58,877,000 | 54,065,000 | 48,365,000 | 41,255,000 | 40,343,000 | 39,563,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $10M | $13M | $10M | $15M | $12M | $8M | $7M | $8M | $7M | $6M | $5M | $5M | |
| Deferred Tax | $-3.0K | $-2.0K | $0 | $-7.0K | $-9.0K | $-8.0K | $-6.0K | $-29.0K | $12.0K | $-31.0K | $-330.0K | $110.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $3M | $3M | $3M | |
| Restructuring | $3M | $0 | $3M | $3M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $10M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-49M | $-53M | $11M | $-14M | $-16M | $-13M | $-14M | $-9M | $-2M | $-433.0K | $321.0K | |
| CapEx | $4M | $4M | $4M | $8M | $14M | $4M | $4M | $3M | $985.0K | $888.0K | $1M | $302.0K | |
| Investing Cash Flow | $24M | $-57M | $-5M | $-14M | $-21M | $-6M | $-4M | $-3M | $-983.0K | $-846.0K | $-1M | $5M | |
| Debt Issued | $10M | $30M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $10M | $30M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $17M | $31M | $9M | $0 | $0 | $86M | $0 | $37M | $24M | $0 | $0 | $9.0K | |
| Net Stock Activity | $17M | $31M | $9M | $0 | $0 | $86M | $50M | · | $24M | $0 | $0 | $9.0K | |
| Financing Cash Flow | $28M | $61M | $8M | $-575.0K | $4M | $81M | $54M | $39M | $22M | $-490.0K | $-2M | $-611.0K | |
| Net Change in Cash | $32M | $-46M | $-49M | $-3M | $-32M | $59M | $38M | $22M | $12M | $-3M | $-3M | $4M | |
| Taxes Paid | · | $17.0K | $194.0K | $100.0K | $102.0K | $312.0K | $5.0K | $5.0K | $32.0K | $5.0K | $8.0K | $15.0K | |
| Free Cash Flow | $-24M | $-54M | $-57M | $3M | $-28M | $-20M | $-16M | $-17M | $-10M | $-4M | $-2M | $19.0K |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| Net Margin | -62.5% | -110.0% | -108.7% | -24.2% | -20.3% | -34.8% | -17.4% | -17.9% | -46.0% | -17.5% | -18.1% | -54.0% | |
| Pretax Margin | -62.4% | -109.9% | -108.6% | -24.0% | -20.1% | -34.3% | -17.4% | -18.0% | -45.8% | -17.6% | -18.9% | -54.7% | |
| EBITDA Margin | -51.8% | -90.3% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| ROA | -29.6% | -45.7% | -39.4% | -13.5% | -9.1% | -13.0% | -10.4% | -16.4% | -51.5% | -21.3% | -16.3% | -35.7% | |
| ROE | -82.8% | -93.0% | -85.6% | -22.5% | -12.8% | -18.4% | -11.5% | -19.6% | -98.6% | -40.8% | -30.8% | -56.3% | |
| ROIC | -46.1% | -61.1% | -78.7% | -24.3% | -13.9% | -14.3% | -11.9% | -20.0% | -92.8% | -44.6% | -32.5% | -71.7% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 | 7.4 | 7.4 | 3.8 | 1.8 | 2.2 | 2.2 | 2.4 | |
| Quick Ratio | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 | 6.5 | 6.5 | 3.6 | 1.7 | 2.0 | 2.1 | 2.2 | |
| Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · | |
| LT Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.6 | 0.9 | 1.1 | 1.2 | 0.9 | 0.7 | |
| Inventory Turnover | 5.2 | 7.3 | 5.4 | 23.9 | 20.9 | 20.6 | 32.6 | 15.5 | 15.4 | 10.7 | 5.5 | 6.7 | |
| Receivables Turnover | · | · | 3.3 | 4.9 | 5.4 | 6.0 | 6.7 | 5.3 | 5.6 | 7.4 | 7.5 | 7.6 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 18.6% | -15.4% | -49.4% | 32.3% | 51.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -20.2% | -17.3% | 0.52% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.38% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Net Income TTM | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Market Cap | $147M | $390M | $213M | $307M | $2.04B | $1.40B | $941M | $912M | $404M | $190M | $171M | $100M | |
| Enterprise Value | $109M | $346M | · | · | · | · | · | · | $373M | · | · | · | |
| P/E | -3.3 | -5.4 | -2.7 | -9.1 | -94.8 | -54.6 | -76.1 | · | · | · | · | · | |
| P/S | 2.1 | 6.6 | 3.0 | 2.2 | 19.4 | 20.3 | 13.8 | 15.0 | 8.1 | 3.9 | 4.1 | 2.8 | |
| P/B | 2.9 | 5.8 | 2.5 | 2.1 | 12.4 | 8.2 | 8.9 | 16.2 | 16.5 | 9.9 | 7.5 | 3.8 | |
| P / Tangible Book | 3.1 | 6.1 | 2.5 | 2.2 | 12.6 | 8.4 | · | · | · | · | · | · | |
| P / Cash Flow | -7.6 | -7.9 | -4.1 | 27.2 | -142.7 | -85.2 | -75.0 | -64.7 | -46.1 | -70.3 | -394.1 | 310.6 | |
| P / FCF | -6.2 | -7.3 | -3.7 | 103.0 | -72.5 | -69.4 | -57.8 | -54.1 | -41.4 | -52.9 | -104.6 | 5247.3 | |
| EV / EBITDA | -3.0 | -6.5 | · | · | · | · | · | · | -16.2 | · | · | · | |
| EV / FCF | -4.6 | -6.4 | · | · | · | · | · | · | -38.3 | · | · | · | |
| EV / Revenue | 1.6 | 5.8 | · | · | · | · | · | · | 7.5 | · | · | · | |
| Earnings Yield | -30.7% | -18.7% | -36.7% | -10.9% | -1.1% | -1.8% | -1.3% | · | · | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $15M | $39M | $9M | $15M | $8M | $21M | $13M | $8M | $17M | $27M | $9M | $21M | $13M | $30M | $34M | |
| Cost of Revenue | $4M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $3M | $5M | $3M | $2M | $3M | $5M | $8M | $10M | |
| R&D Expense | $12M | $11M | $12M | $14M | $14M | $13M | $12M | $12M | $11M | $11M | $11M | $14M | $17M | $17M | $20M | $22M | |
| SG&A Expense | $11M | $10M | $11M | $11M | $12M | $12M | $13M | $14M | $16M | $13M | $12M | $12M | $13M | $15M | $12M | $13M | |
| Operating Expenses | $26M | $23M | $28M | $28M | $28M | $28M | $29M | $29M | $31M | $29M | $26M | $41M | $34M | $37M | $44M | $45M | |
| Operating Income | $-11M | $-8M | $11M | $-19M | $-13M | $-20M | $-7M | $-17M | $-23M | $-12M | $282.0K | $-32M | $-13M | $-24M | $-13M | $-11M | |
| Interest Income | $535.0K | $665.0K | $656.0K | $634.0K | $584.0K | $751.0K | $940.0K | $849.0K | $972.0K | $909.0K | $906.0K | $1M | $1M | $1M | $823.0K | $436.0K | |
| Other Non-op | $-1M | $-1M | $-2M | $-1M | $-984.0K | $-942.0K | $-4M | $-5M | $-985.0K | $-516.0K | $-8M | $-4M | $-9.0K | $-25.0K | $-26.0K | $216.0K | |
| Pretax Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-11M | $-7M | $-35M | $-12M | $-23M | $-12M | $-10M | |
| Income Tax | $10.0K | $36.0K | $18.0K | $8.0K | $10.0K | $11.0K | $4.0K | $10.0K | $10.0K | $10.0K | $35.0K | $9.0K | $9.0K | $16.0K | $151.0K | $8.0K | |
| Net Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-12M | $-7M | $-35M | $-12M | $-23M | $-13M | $-10M | |
| EPS (Basic) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| EPS (Diluted) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| Shares (Basic) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| Shares (Diluted) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| EBITDA | $-11M | · | · | $-19M | $-13M | $-19M | · | $-17M | $-23M | $-12M | · | $-32M | $-13M | $-24M | · | $-11M |
Bilans 27
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $37M | $51M | $25M | $27M | $18M | $19M | $37M | $19M | $58M | $65M | $75M | $92M | $103M | $114M | $109M | |
| Short-term Investments | $28M | $29M | $27M | $33M | $40M | $41M | $54M | $53M | $55M | $27M | · | · | · | · | · | · | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $3M | $4M | $6M | $5M | $3M | $4M | $4M | $3M | $3M | $5M | · | $5M | $4M | $5M | · | $5M | |
| Other Current Assets | $500.0K | $400.0K | $500.0K | $500.0K | $100.0K | $500.0K | $500.0K | $300.0K | $900.0K | $500.0K | · | · | · | · | · | · | |
| Current Assets | $72M | $80M | $97M | $76M | $89M | $78M | $99M | $113M | $91M | $108M | · | $103M | $120M | $130M | · | $146M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $14M | $13M | $14M | $15M | · | $15M | $23M | $24M | · | $23M | |
| PP&E (Gross) | $59M | $59M | $58M | $58M | $58M | $57M | $55M | $54M | $54M | $55M | · | $54M | $66M | $65M | · | $63M | |
| Accum. Depreciation | $47M | $46M | $45M | $44M | $43M | $42M | $41M | $41M | $40M | $40M | · | $39M | $42M | $41M | · | $39M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $1M | $994.0K | $883.0K | $912.0K | $950.0K | $967.0K | $1M | $2M | $2M | $1M | · | $726.0K | $498.0K | $415.0K | · | $208.0K | |
| Total Assets | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $1M | $6M | $3M | $4M | $4M | $3M | · | $3M | $4M | $4M | · | $3M | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $3M | $5M | $6M | $7M | $5M | $5M | · | $9M | $7M | $8M | · | $13M | |
| Current Liabilities | $24M | $15M | $25M | $18M | $15M | $21M | $24M | $35M | $31M | $29M | · | $38M | $36M | $38M | · | $32M | |
| Capital Leases | $28M | $29M | $30M | $26M | $27M | $27M | $28M | $9M | $10M | $11M | · | $13M | $35M | $37M | · | $40M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $87M | $86M | $97M | $85M | $83M | $79M | $82M | $75M | $71M | $70M | · | $63M | $83M | $92M | · | $81M | |
| Long-term Debt | $41M | $40M | $40M | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Total Debt | $41M | · | · | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $660M | $659M | $657M | $655M | $652M | $633M | $630M | $626M | $593M | $588M | · | $582M | $580M | $570M | · | $563M | |
| Retained Earnings | $-627M | $-615M | $-607M | $-616M | $-597M | $-583M | $-563M | $-552M | $-532M | $-509M | · | $-490M | $-455M | $-444M | · | $-409M | |
| AOCI | $-13.0K | $-11.0K | $8.0K | $12.0K | $-3.0K | $14.0K | $52.0K | $126.0K | $-23.0K | $-16.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $43M | $51M | $39M | $56M | $50M | $67M | $73M | $61M | $79M | $87M | $92M | $124M | $126M | $145M | $154M | |
| Liabilities + Equity | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Shares Outstanding | 91,388,000 | 90,894,000 | 90,478,000 | 90,281,000 | 90,254,000 | 82,841,000 | 81,850,000 | 81,376,000 | 70,914,000 | 70,554,000 | · | 69,827,000 | 69,804,000 | 66,696,000 | · | 65,613,000 |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Stock-based Comp | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | |
| Restructuring | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $72.0K | $72.0K | $3M | $0 | |
| Other Non-cash | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $-13M | $20M | $-8M | $-18M | $-14M | $-16M | $-13M | $-12M | $-8M | $-11M | $-16M | $-16M | $-9M | $5M | $20M | |
| CapEx | $898.0K | $176.0K | $520.0K | $182.0K | $3M | $1M | $2M | $1M | $395.0K | $1M | $-380.0K | $678.0K | $2M | $3M | $-33.0K | $1M | |
| Investing Cash Flow | $175.0K | $-1M | $6M | $6M | $-367.0K | $12M | $-3M | $2M | $-27M | $-29M | $1M | $-1M | $-2M | $-3M | $33.0K | $-1M | |
| Debt Issued | · | · | $0 | $0 | $10M | $0 | $0 | $0 | $0 | $30M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $30M | · | · | · | · | · | · | |
| Stock Issued | · | · | $-1.0K | $0 | · | · | $-1.0K | $31M | $0 | $0 | $0 | $0 | $7M | $2M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $66.0K | $-14.0K | $180.0K | $-111.0K | $27M | $1M | $1M | $30M | $-197.0K | $29M | $0 | $-108.0K | $7M | $1M | $339.0K | $133.0K | |
| Net Change in Cash | $-9M | $-14M | $26M | $-1M | $8M | $-944.0K | $-18M | $19M | $-39M | $-7M | $-10M | $-18M | $-11M | $-11M | $5M | $19M | |
| Taxes Paid | · | · | · | · | · | $0 | · | · | · | $17.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | $-9M | · | · | · | $-12M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -75.3% | · | · | -220.3% | -83.9% | -271.6% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| Net Margin | -80.5% | · | · | -228.1% | -86.6% | -274.3% | · | -160.8% | -285.2% | -67.4% | · | -376.3% | -54.0% | -174.2% | · | -29.0% | |
| Pretax Margin | -80.4% | · | · | -228.0% | -86.5% | -274.1% | · | -160.8% | -285.1% | -67.3% | · | -376.2% | -54.0% | -174.1% | · | -29.0% | |
| EBITDA Margin | -75.3% | · | · | -220.3% | -83.9% | -255.8% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| ROA | -9.3% | · | · | -14.4% | -9.8% | -14.9% | · | -13.6% | -13.4% | -6.3% | · | -17.9% | -5.2% | -10.0% | · | -4.3% | |
| ROE | -27.1% | · | · | -35.0% | -22.7% | -32.1% | · | -25.0% | -24.5% | -11.2% | · | -28.4% | -8.1% | -15.9% | · | -6.2% | |
| ROIC | -15.2% | · | · | -24.2% | -13.6% | -26.0% | · | -16.2% | -25.3% | -11.1% | · | -35.0% | -10.2% | -18.8% | · | -6.9% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 4.1 | 5.8 | 3.7 | · | 3.2 | 3.0 | 3.7 | · | 2.7 | 3.4 | 3.4 | · | 4.6 | |
| Quick Ratio | 2.3 | · | · | 3.2 | 4.4 | 2.9 | · | 2.6 | 2.4 | 2.9 | · | 1.9 | 2.6 | 2.7 | · | 3.4 | |
| Debt / Equity | 1.2 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · | |
| LT Debt / Equity | 1.0 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 2.0 | · | · | 1.2 | 1.0 | 1.3 | · | 2.0 | 1.6 | 2.2 | · | 1.1 | 1.7 | 2.5 | · | 7.2 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $47M | · | $44M | $44M | $45M | · | $47M | $56M | $61M | · | $78M | $107M | $121M | · | $145M | |
| Net Income TTM | $-54M | $-62M | · | $-74M | $-77M | $-76M | · | $-90M | $-81M | $-81M | · | $-79M | $-47M | $-44M | · | $-19M | |
| Market Cap | $207M | · | · | $220M | $220M | $223M | · | $251M | $220M | $246M | · | $132M | $195M | $276M | · | $398M | |
| Enterprise Value | $192M | · | · | $201M | $193M | $192M | · | $189M | $175M | $189M | · | · | · | · | · | · | |
| P/E | -3.7 | -2.2 | · | -2.7 | -2.4 | -2.6 | · | -2.4 | -2.7 | -3.0 | · | -1.6 | -4.0 | -6.3 | · | -20.9 | |
| P/S | 3.8 | · | · | 5.0 | 5.0 | 4.9 | · | 5.3 | 4.0 | 4.1 | · | 1.7 | 1.8 | 2.3 | · | 2.7 | |
| P/B | 6.3 | · | · | 5.7 | 4.0 | 4.5 | · | 3.4 | 3.6 | 3.1 | · | 1.4 | 1.6 | 2.2 | · | 2.6 | |
| P / Tangible Book | 6.8 | 3.6 | · | 6.1 | 4.1 | 4.7 | · | 3.5 | 3.7 | 3.2 | · | 1.5 | 1.6 | 2.2 | · | 2.6 | |
| P / Cash Flow | · | · | · | · | · | -16.2 | · | · | · | -31.6 | · | · | · | -30.0 | · | · | |
| P / FCF | · | · | · | · | · | -14.8 | · | · | · | -27.6 | · | · | · | -23.5 | · | · | |
| EV / EBITDA | -17.1 | · | · | -10.6 | -15.0 | -10.0 | · | -11.4 | -7.7 | -15.9 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -12.8 | · | · | · | -21.2 | · | · | · | · | · | · | |
| EV / Revenue | 3.6 | · | · | 4.5 | 4.4 | 4.2 | · | 4.0 | 3.1 | 3.1 | · | · | · | · | · | · | |
| Earnings Yield | -27.0% | -44.8% | · | -37.7% | -41.8% | -37.9% | · | -41.2% | -37.1% | -33.5% | · | -61.4% | -25.0% | -15.9% | · | -4.8% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $70M | $59M | $70M | $139M | $105M |
| Marża Operacyjna % | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% |
| Zysk netto | $-44M | $-65M | $-76M | $-34M | $-21M |
| Rozwodniony EPS | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.8 | 0.4 | — | — | — |
| Wskaźnik bieżący | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 |
| Wskaźnik Szybkości | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-24M | $-54M | $-57M | $3M | $-28M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 156 emitentów · $120.9M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 32 (0 vs poprzedni kw.) | 11 (-10 vs poprzedni kw.) | 50 (+4 vs poprzedni kw.) | 41 (+8 vs poprzedni kw.) | +1.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Opaleye Management Inc. | $15 334 100 | 6 785 000 | 12,69% | Akcje |
| Aberdeen Group plc | $15 300 096 | 6 769 954 | 12,66% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $12 541 054 | 5 549 139 | 10,38% | Akcje |
| Telemark Asset Management, LLC | $8 692 889 | 3 846 411 | 7,19% | Akcje |
| AMERIPRISE FINANCIAL INC | $8 609 334 | 3 809 440 | 7,12% | Akcje |
| Nantahala Capital Management, LLC | $8 189 365 | 3 623 613 | 6,78% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 174 666 | 3 617 109 | 6,76% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $4 204 899 | 1 860 140 | 3,48% | Akcje |
| STATE STREET CORP | $3 970 400 | 1 756 814 | 3,29% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 006 263 | 1 330 205 | 2,49% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 954 206 | 1 307 171 | 2,44% | Akcje |
| Assenagon Asset Management S.A. | $2 888 746 | 1 278 206 | 2,39% | Akcje |
| D. E. Shaw & Co., Inc. | $2 500 229 | 1 106 296 | 2,07% | Akcje |
| Tallon Kerry Patrick | $2 018 337 | 403 667 | 1,67% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 574 314 | 696 599 | 1,30% | Akcje |
| FRANKLIN RESOURCES INC | $1 533 726 | 678 640 | 1,27% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 313 191 | 581 058 | 1,09% | Akcje |
| Man Group plc | $1 278 240 | 565 593 | 1,06% | Akcje |
| Post Resch Tallon Group Inc. | $1 273 460 | 563 478 | 1,05% | Akcje |
| PERKINS CAPITAL MANAGEMENT INC | $1 188 986 | 526 100 | 0,98% | Akcje |
| ALGERT GLOBAL LLC | $973 857 | 430 910 | 0,81% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $808 910 | 357 925 | 0,67% | Akcje |
| BlackRock, Inc. | $648 681 | 287 027 | 0,54% | Akcje |
| PLATINUM INVESTMENT MANAGEMENT LTD | $597 689 | 264 464 | 0,49% | Akcje |
| Potomac Capital Management, Inc. | $587 600 | 260 000 | 0,49% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $583 674 | 258 263 | 0,48% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $547 397 | 242 211 | 0,45% | Akcje |
| XTX Topco Ltd | $543 817 | 240 627 | 0,45% | Akcje |
| UBS Group AG | $542 188 | 239 906 | 0,45% | Akcje |
| FMR LLC | $457 501 | 202 434 | 0,38% | Akcje |
| GOLDMAN SACHS GROUP INC | $389 726 | 172 445 | 0,32% | Akcje |
| Cubist Systematic Strategies, LLC | $359 610 | 147 381 | 0,30% | Akcje |
| BARCLAYS PLC | $347 740 | 153 867 | 0,29% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $334 595 | 148 051 | 0,28% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $284 552 | 125 908 | 0,24% | Akcje |
| STRS OHIO | $273 460 | 121 000 | 0,23% | Akcje |
| JANE STREET GROUP, LLC | $261 857 | 115 866 | 0,22% | Akcje |
| MARSHALL WACE, LLP | $254 791 | 112 739 | 0,21% | Akcje |
| Stonepine Capital Management, LLC | $247 836 | 109 662 | 0,21% | Akcje |
| RHUMBLINE ADVISERS | $233 449 | 103 301 | 0,19% | Akcje |
| CITADEL ADVISORS LLC | $227 295 | 100 573 | 0,19% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $206 081 | 126 430 | 0,17% | Akcje |
| WELLS FARGO & COMPANY/MN | $176 113 | 77 926 | 0,15% | Akcje |
| Bank of New York Mellon Corp | $174 178 | 77 070 | 0,14% | Akcje |
| LPL Financial LLC | $173 026 | 76 560 | 0,14% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161 879 | 71 628 | 0,13% | Akcje |
| BANK OF AMERICA CORP /DE/ | $145 582 | 64 417 | 0,12% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $144 082 | 63 753 | 0,12% | Akcje |
| Numerai GP LLC | $136 072 | 60 209 | 0,11% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $131 532 | 58 200 | 0,11% | Akcje |
| Mariner, LLC | $123 484 | 54 637 | 0,10% | Akcje |
| MetLife Investment Management, LLC | $117 545 | 52 011 | 0,10% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $116 108 | 51 375 | 0,10% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $108 763 | 48 125 | 0,09% | Akcje |
| IEQ CAPITAL, LLC | $104 559 | 46 265 | 0,09% | Akcje |
| TWO SIGMA ADVISERS, LP | $96 822 | 59 400 | 0,08% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $93 790 | 41 500 | 0,08% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $89 957 | 39 804 | 0,07% | Akcje |
| CITIGROUP INC | $86 660 | 38 345 | 0,07% | Akcje |
| Frec Markets, Inc. | $84 228 | 37 269 | 0,07% | Akcje |
| OSAIC HOLDINGS, INC. | $82 186 | 36 366 | 0,07% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $81 820 | 36 204 | 0,07% | Akcje |
| BANK OF MONTREAL /CAN/ | $79 095 | 34 998 | 0,07% | Akcje |
| Krilogy Financial LLC | $78 705 | 34 825 | 0,07% | Akcje |
| MORGAN STANLEY | $77 462 | 34 275 | 0,06% | Akcje |
| Invesco Ltd. | $77 181 | 34 151 | 0,06% | Akcje |
| Dynamic Technology Lab Private Ltd | $74 000 | 33 000 | 0,06% | Akcje |
| Vanguard Global Advisers, LLC | $73 681 | 32 602 | 0,06% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $73 111 | 32 350 | 0,06% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $68 932 | 30 501 | 0,06% | Akcje |
| BLAIR WILLIAM & CO/IL | $68 295 | 30 219 | 0,06% | Akcje |
| EVERGREEN CAPITAL MANAGEMENT LLC | $65 540 | 29 000 | 0,05% | Akcje |
| CWM, LLC | $63 696 | 39 077 | 0,05% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $61 418 | 25 275 | 0,05% | Akcje |
| Nuveen Asset Management, LLC | $59 902 | 12 558 | 0,05% | Akcje |
| PRUDENTIAL FINANCIAL INC | $59 619 | 26 380 | 0,05% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56 963 | 25 205 | 0,05% | Akcje |
| Cerity Partners LLC | $53 695 | 23 759 | 0,04% | Akcje |
| VANGUARD GROUP INC | $53 141 | 32 602 | 0,04% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $48 486 | 21 454 | 0,04% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $45 426 | 20 100 | 0,04% | Opcja kupna |
| Police & Firemen's Retirement System of New Jersey | $43 937 | 19 441 | 0,04% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $41 948 | 18 561 | 0,03% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $40 562 | 17 948 | 0,03% | Akcje |
| Simplicity Wealth,LLC | $39 410 | 17 438 | 0,03% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $38 167 | 16 888 | 0,03% | Akcje |
| CITADEL ADVISORS LLC | $35 708 | 15 800 | 0,03% | Opcja kupna |
| Creative Planning | $35 003 | 15 488 | 0,03% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $34 942 | 15 461 | 0,03% | Akcje |
| Navalign, LLC | $34 668 | 15 340 | 0,03% | Akcje |
| EP Wealth Advisors, LLC | $34 526 | 15 277 | 0,03% | Akcje |
| China Universal Asset Management Co., Ltd. | $32 693 | 14 466 | 0,03% | Akcje |
| ProShare Advisors LLC | $32 324 | 14 303 | 0,03% | Akcje |
| Elmwood Wealth Management, Inc. | $28 691 | 12 695 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $27 992 | 12 386 | 0,02% | Akcje |
| OXFORD ASSET MANAGEMENT LLP | $27 335 | 12 095 | 0,02% | Akcje |
| Graham Capital Management, L.P. | $27 287 | 12 074 | 0,02% | Akcje |
| Tower Research Capital LLC (TRC) | $27 244 | 12 055 | 0,02% | Akcje |
| Abel Hall, LLC | $26 930 | 11 916 | 0,02% | Akcje |
| Caerus Investment Advisors, LLC | $26 297 | 11 636 | 0,02% | Akcje |
Insiderzy spółki 40 insiderów · 19 dyrektorzy generalni · 20 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John J Nicols | President and CEO | 11 czerwca 2018 M | 1 072 679 | 0 | 0 | $0 |
| Peter M Strumph | Interim President and CEO | 1 czerwca 2012 A | 60 756 | 0 | 0 | $0 |
| Alan Shaw | President and CEO | 16 grudnia 2011 S | 202 000 | 0 | 0 | $0 |
| Georgia Erbez | Chief Financial Officer | 5 lutego 2025 A | 76 875 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 1 stycznia 2024 A | 175 791 | 0 | 0 | $0 |
| Gordon Sangster | SVP & Chief Financial Officer | 24 maja 2018 S | 153 189 | 0 | 0 | $0 |
| David D O'Toole | SVP & Chief Financial Officer | 4 września 2013 F | 110 687 | 0 | 0 | $0 |
| Brian Paul Dowd | Interim CFO | 1 czerwca 2012 A | 28 310 | 0 | 0 | $0 |
| Robert J Lawson | SVP and CFO | 11 maja 2011 P | 44 000 | 0 | 0 | $0 |
| Kevin Norrett | Chief Operating Officer | 5 lutego 2025 A | 177 327 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 5 lutego 2025 A | 175 571 | 0 | 0 | $0 |
| Margaret Nell Fitzgerald | Chief Legal and Compliance Officer | 1 stycznia 2024 A | 133 770 | 0 | 0 | $0 |
| James Lalonde | SVP, R&D | 17 lipca 2018 S | 195 066 | 0 | 0 | $0 |
| Michael D. Aldridge | Senior Vice President, Corporate & Strategic Development | 17 maja 2018 M | 0 | 0 | 0 | $0 |
| Douglas T. Sheehy | EVP, Chief Administrative Officer, General Counsel & Secretary | 5 marca 2016 F | 247 617 | 0 | 0 | $0 |
| Matthew Tobin | SVP, Research & Development | 16 maja 2013 M | 78 707 | 0 | 0 | $0 |
| David L. Anton | SVP, BioIndustrials | 10 lutego 2013 F | 93 777 | 0 | 0 | $0 |
| Seufer-Wasserthal Peter | SVP, Pharmaceuticals | 24 stycznia 2013 A | 93 064 | 0 | 0 | $0 |
| Joseph J. Sarret | SVP and CBO | 7 marca 2012 A | 74 000 | 0 | 0 | $0 |
| Raymond De Vre | Dyrektor | 17 czerwca 2026 A | 84 811 | 0 | 1 | $-6 174 |
| Esther Martinborough | Dyrektor | 17 czerwca 2026 A | 129 036 | 0 | 0 | $0 |
| Christos Richards | Dyrektor | 17 czerwca 2026 A | 85 133 | 0 | 0 | $0 |
| Cynthia Collins | Dyrektor | 17 czerwca 2026 A | 112 157 | 0 | 0 | $0 |
| Stephen George Dilly | Dyrektor | 17 czerwca 2026 A | 673 053 | 0 | 0 | $0 |
| Rahul Singhvi | Dyrektor | 17 czerwca 2026 A | 137 052 | 0 | 0 | $0 |
| David V Smith | Dyrektor | 17 czerwca 2026 A | 105 705 | 0 | 0 | $0 |
| PARKER H STEWART | Dyrektor | 17 czerwca 2026 A | 143 583 | 0 | 0 | $0 |
| Dennis P Wolf | Dyrektor | 10 czerwca 2025 A | 147 903 | 0 | 0 | $0 |
| Byron L Dorgan | Dyrektor | 11 czerwca 2024 A | 223 581 | 0 | 0 | $0 |
| Patrick Y Yang | Dyrektor | 19 lipca 2018 S | 304 157 | 0 | 0 | $0 |
| Kathleen Sereda Glaub | Dyrektor | 18 lipca 2018 S | 98 120 | 0 | 0 | $0 |
| Thomas R Baruch | Dyrektor | 26 czerwca 2018 S | 153 093 | 0 | 0 | $0 |
| Bernard J Kelley | Dyrektor | 21 czerwca 2018 S | 225 668 | 0 | 0 | $0 |
| Pam P. Cheng | Dyrektor | 11 czerwca 2018 A | 64 642 | 0 | 0 | $0 |
| Alexander Karsner | Dyrektor | 2 stycznia 2014 A | 78 519 | 0 | 0 | $0 |
| Bruce A Pasternack | Dyrektor | 24 sierpnia 2010 P | 10 000 | 0 | 0 | $0 |
| James R Sulat | Dyrektor | 27 kwietnia 2010 J | 5 957 108 | 0 | 0 | $0 |
| Brazil Holding B.V. Shell | Posiadacz 10% | 31 maja 2011 J | 5 573 319 | 0 | 0 | $0 |
| Equilon Enterprises LLC | Posiadacz 10% | 20 maja 2011 J | 5 573 319 | 0 | 0 | $0 |
| MAXYGEN INC | Posiadacz 10% | 14 grudnia 2010 J | 524 643 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| John Nicols | 16 lutego 2021 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 zgłoszenia | 26 maja 2015 | — | Pierwotne zgłoszenie | — | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED | 7 czerwca 2011 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 26 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| BIB · ProShares Trust | 0,01% | 3 341 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 38 712 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 4 198 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 3 283 NS | 31 maja 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28 868 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 3 320 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 83 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 52 788 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2 554 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 729 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 19 277 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| IWV · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | — | — | 17 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 lipca 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 lipca 2026 | Dziennie |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 20 lipca 2026 | Dziennie |